Enteral feeding devices refer to medical devices used to deliver nutrition directly into the digestive tract, bypassing the oral cavity. These devices are used when patients cannot take food orally or have difficulty swallowing or digesting food.
In 2021, the market for enteral feeding devices was worth USD 3.48 billion, and by 2030 it will be worth USD 6.088 billion, at a 6.38% CAGR during the forecast period.
The enteral feeding devices market is growing significantly due to factors such as the increasing rate of chronic diseases, expanding geriatric population, and the rising demand for home healthcare services. Enteral feeding devices are also used more frequently in critical care settings, as they offer a safer and more effective method of providing nutrition to critically ill patients.
The market is evolving due to the increased prevalence of chronic diseases and malnutrition, as well as the rising demand from the home care sector and the growing older population. There is an increasing need for nutritional sustenance provided by enteral feeding systems because of the expanding older population with chronic conditions that limit swallowing, such as organ failure, multiple sclerosis, stroke, and dementia. Patients who have had a stroke may also become malnourished, which increases the need for enteral feeding apparatus. According to NCBI articles, malnutrition is thought to affect stroke patients between 8% and 34% of the time.
The rising number of malnourished is a key factor propelling the market growth. Enteral feeding is necessary to provide nutritional nutrients to kids with digestive issues. Malnutrition places a heavy burden on society, requiring the use of feeding tubes for people with digestive and metabolic issues. According to research, 40% of hospitalized patients are malnourished, increasing morbidity and mortality risk. Therefore, enteral feeding is the preferred choice for these patients to give those who cannot eat calories enough calories.
The rising number of critical illnesses, GI dysfunction, aspiration, neurological or movement disorders, refeeding syndrome, nausea and vomiting, skin irritation, diarrhea, tube dislodgement, and tube blockage are impeding the global market’s overall growth.
Due to its high-quality and various healthcare markets, expanding frequency of R&D activities for creating innovative feeding technologies, the ongoing rise in chronic illnesses and infectious diseases, etc., the APAC region will provide significant growth prospects in the future.
The enteral feeding pumps segment had the highest revenue share of more than 40% in 2021. Enteral-based feeding or nutrition is frequent for the pediatric and adult population with chronic diseases to promote nutrient uptake and prevent malnutrition. These disorders restrict oral nutrition intake, which drives segment growth. This market’s expansion is also due to the increasing use of these safe, nutrient-dense devices in hospitals and at-home care settings.
In 2021, the gastrointestinal sector had the biggest market proportion of nearly 32.11%. Patients with gastrointestinal problems typically cannot absorb nutrients for proper bodily function.
Hospitals generated 47.54% of the market’s revenue in 2021. Hospitals are using more enteral feeding systems as a result of a large number of patients being hospitalized. Enteral feeding devices must be used during general and specialty operations since the majority of patients are unable to absorb nutrition.
In terms of revenue, North America had a market share of roughly 38% in 2021. This is due to the expanding geriatric population, the rising prevalence of chronic diseases like digestive disorders, neurological conditions, and organ failure, and the rising prevalence of lifestyle disorders and other diseases like diabetes, cancer, and autism.
During the predicted period, Asia Pacific will have the fastest CAGR. An increase in hospital admissions, the senior population, malnourished patients, and preterm births are some of the causes influencing regional growth.
- Boston Scientific Corporation
- Becton, Dickinson, and Company
- Fresenius Kabi
- Vygon Group
- CONMED Corporation
- Cardinal Health Inc.
- Moog Inc.
- Danone S.A.
- Cook Medical
- B. Braun Melsungen AG
- Avanos Medical Inc
- Nestlé S.A.
- Baxter International Inc.
- Applied Medical Technology
- Danumed Medizintechnik
- Amsino International Inc.
- Omex Medical Technology
- Fuji Systems Corporation
- Vesco Medical LLC
- Medela Inc.
- Kentec Medical Inc.
- Medline Industries, Inc.
- Dynarex Corporation
- Alcor Scientific
In 2021, the market for enteral feeding devices was worth USD 3.48 billion, and by 2030 it will be worth USD 6.088 billion, at a 6.38% CAGR during the forecast period. The market is expanding due to factors such as the rising geriatric population, rising home care sector demand, and rising prevalence of chronic illnesses and malnutrition.
Wearable Injectors Market Report – The global wearable injectors market will witness a robust CAGR of 12.46%, valued at $6.17 billion in 2021, expected to appreciate and reach $17.75 billion by 2030, confirms Strategic Market Research.